Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Index by author

February 01, 1985; Volume 27,Issue 2
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Akamatsu, N

    1. You have access
      Age-related alterations in the catecholamine-sensitive adenylate cyclase system of the prostate.
      S Shima, N Akamatsu, M Hirai and H Kouyama
      Molecular Pharmacology February 1985, 27 (2) 218-222;
  2. Albuquerque, E X

    1. You have access
      Triphenylmethylphosphonium blocks the nicotinic acetylcholine receptor noncompetitively.
      C E Spivak and E X Albuquerque
      Molecular Pharmacology February 1985, 27 (2) 246-255;

B

  1. Bergman, A

    1. You have access
      Target cells for the polychlorinated biphenyl metabolite 4,4'-bis(methylsulfonyl)-2,2',5,5'-tetrachlorobiphenyl. Characterization of high affinity binding in rat and mouse lung cytosol.
      J Lund, I Brandt, L Poellinger, A Bergman, E Klasson-Wehler and J A Gustafsson
      Molecular Pharmacology February 1985, 27 (2) 314-323;
  2. Billings, R E

    1. You have access
      Bromobenzene metabolism in isolated rat hepatocytes. 18O2 incorporation studies.
      D Dankovic, R E Billings, W Seifert and W G Stillwell
      Molecular Pharmacology February 1985, 27 (2) 287-295;
  3. Brandt, I

    1. You have access
      Target cells for the polychlorinated biphenyl metabolite 4,4'-bis(methylsulfonyl)-2,2',5,5'-tetrachlorobiphenyl. Characterization of high affinity binding in rat and mouse lung cytosol.
      J Lund, I Brandt, L Poellinger, A Bergman, E Klasson-Wehler and J A Gustafsson
      Molecular Pharmacology February 1985, 27 (2) 314-323;
  4. Brodersen, R

    1. You have access
      Interaction of warfarin with human serum albumin. A stoichiometric description.
      F G Larsen, C G Larsen, P Jakobsen and R Brodersen
      Molecular Pharmacology February 1985, 27 (2) 263-270;

C

  1. Carter, E A

    1. You have access
      Rapid reciprocal changes in adrenergic receptors in intact isolated hepatocytes during primary cell culture.
      K R Schwarz, S M Lanier, E A Carter, C J Homcy and R M Graham
      Molecular Pharmacology February 1985, 27 (2) 200-209;
  2. Cohen, M B

    1. You have access
      Cytotoxicity and the inhibition of ribosomal RNA processing in human colon carcinoma cells.
      M B Cohen and R I Glazer
      Molecular Pharmacology February 1985, 27 (2) 308-313;
  3. Creese, I

    1. You have access
      Interactions of dopamine agonists with brain D1 receptors labeled by 3H-antagonists. Evidence for the presence of high and low affinity agonist-binding states.
      S E Leff, M W Hamblin and I Creese
      Molecular Pharmacology February 1985, 27 (2) 171-183;
    2. You have access
      Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum. Evidence that [3H]dopamine can label a high affinity agonist-binding state of the D1 dopamine receptor.
      S E Leff and I Creese
      Molecular Pharmacology February 1985, 27 (2) 184-192;
  4. Crooke, S T

    1. You have access
      Characterization of guinea pig myocardial leukotriene C4 binding sites. Regulation by cations and sulfhydryl-directed reagents.
      G K Hogaboom, S Mong, J M Stadel and S T Crooke
      Molecular Pharmacology February 1985, 27 (2) 236-245;

D

  1. Danenberg, P V

    1. You have access
      Assay and time course of 5-fluorouracil incorporation into RNA of L1210/0 ascites cells in vivo.
      C P Spears, J Shani, A H Shahinian, W Wolf, C Heidelberger and P V Danenberg
      Molecular Pharmacology February 1985, 27 (2) 302-307;
  2. Dankovic, D

    1. You have access
      Bromobenzene metabolism in isolated rat hepatocytes. 18O2 incorporation studies.
      D Dankovic, R E Billings, W Seifert and W G Stillwell
      Molecular Pharmacology February 1985, 27 (2) 287-295;

G

  1. Glazer, R I

    1. You have access
      Cytotoxicity and the inhibition of ribosomal RNA processing in human colon carcinoma cells.
      M B Cohen and R I Glazer
      Molecular Pharmacology February 1985, 27 (2) 308-313;
  2. Graham, R M

    1. You have access
      Rapid reciprocal changes in adrenergic receptors in intact isolated hepatocytes during primary cell culture.
      K R Schwarz, S M Lanier, E A Carter, C J Homcy and R M Graham
      Molecular Pharmacology February 1985, 27 (2) 200-209;
  3. Guan, J H

    1. You have access
      A photoaffinity ligand for dopamine D2 receptors: azidoclebopride.
      H B Niznik, J H Guan, J L Neumeyer and P Seeman
      Molecular Pharmacology February 1985, 27 (2) 193-199;
  4. Gullberg, D

    1. You have access
      Characterization of the hydrophobic properties of the receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin.
      L Poellinger and D Gullberg
      Molecular Pharmacology February 1985, 27 (2) 271-276;
  5. Gustafsson, J A

    1. You have access
      Target cells for the polychlorinated biphenyl metabolite 4,4'-bis(methylsulfonyl)-2,2',5,5'-tetrachlorobiphenyl. Characterization of high affinity binding in rat and mouse lung cytosol.
      J Lund, I Brandt, L Poellinger, A Bergman, E Klasson-Wehler and J A Gustafsson
      Molecular Pharmacology February 1985, 27 (2) 314-323;

H

  1. Hamblin, M W

    1. You have access
      Interactions of dopamine agonists with brain D1 receptors labeled by 3H-antagonists. Evidence for the presence of high and low affinity agonist-binding states.
      S E Leff, M W Hamblin and I Creese
      Molecular Pharmacology February 1985, 27 (2) 171-183;
  2. Heidelberger, C

    1. You have access
      Assay and time course of 5-fluorouracil incorporation into RNA of L1210/0 ascites cells in vivo.
      C P Spears, J Shani, A H Shahinian, W Wolf, C Heidelberger and P V Danenberg
      Molecular Pharmacology February 1985, 27 (2) 302-307;
  3. Hirai, M

    1. You have access
      Age-related alterations in the catecholamine-sensitive adenylate cyclase system of the prostate.
      S Shima, N Akamatsu, M Hirai and H Kouyama
      Molecular Pharmacology February 1985, 27 (2) 218-222;
  4. Hoffman, B B

    1. You have access
      Desensitization of beta-adrenergic receptor-mediated vascular smooth muscle relaxation.
      G Tsujimoto and B B Hoffman
      Molecular Pharmacology February 1985, 27 (2) 210-217;
  5. Hogaboom, G K

    1. You have access
      Characterization of guinea pig myocardial leukotriene C4 binding sites. Regulation by cations and sulfhydryl-directed reagents.
      G K Hogaboom, S Mong, J M Stadel and S T Crooke
      Molecular Pharmacology February 1985, 27 (2) 236-245;
  6. Homcy, C J

    1. You have access
      Rapid reciprocal changes in adrenergic receptors in intact isolated hepatocytes during primary cell culture.
      K R Schwarz, S M Lanier, E A Carter, C J Homcy and R M Graham
      Molecular Pharmacology February 1985, 27 (2) 200-209;

J

  1. Jakobsen, P

    1. You have access
      Interaction of warfarin with human serum albumin. A stoichiometric description.
      F G Larsen, C G Larsen, P Jakobsen and R Brodersen
      Molecular Pharmacology February 1985, 27 (2) 263-270;
  2. Johnson, E F

    1. You have access
      Variations among untreated rabbits in benzo(a)pyrene metabolism and its modulation by 7,8-benzoflavone.
      J L Raucy and E F Johnson
      Molecular Pharmacology February 1985, 27 (2) 296-301;

K

  1. Klasson-Wehler, E

    1. You have access
      Target cells for the polychlorinated biphenyl metabolite 4,4'-bis(methylsulfonyl)-2,2',5,5'-tetrachlorobiphenyl. Characterization of high affinity binding in rat and mouse lung cytosol.
      J Lund, I Brandt, L Poellinger, A Bergman, E Klasson-Wehler and J A Gustafsson
      Molecular Pharmacology February 1985, 27 (2) 314-323;
  2. Kouyama, H

    1. You have access
      Age-related alterations in the catecholamine-sensitive adenylate cyclase system of the prostate.
      S Shima, N Akamatsu, M Hirai and H Kouyama
      Molecular Pharmacology February 1985, 27 (2) 218-222;

L

  1. Lanier, S M

    1. You have access
      Rapid reciprocal changes in adrenergic receptors in intact isolated hepatocytes during primary cell culture.
      K R Schwarz, S M Lanier, E A Carter, C J Homcy and R M Graham
      Molecular Pharmacology February 1985, 27 (2) 200-209;
  2. Larsen, C G

    1. You have access
      Interaction of warfarin with human serum albumin. A stoichiometric description.
      F G Larsen, C G Larsen, P Jakobsen and R Brodersen
      Molecular Pharmacology February 1985, 27 (2) 263-270;
  3. Larsen, F G

    1. You have access
      Interaction of warfarin with human serum albumin. A stoichiometric description.
      F G Larsen, C G Larsen, P Jakobsen and R Brodersen
      Molecular Pharmacology February 1985, 27 (2) 263-270;
  4. Larsson, R

    1. You have access
      Characterization and mechanism of formation of reactive products formed during peroxidase-catalyzed oxidation of p-phenetidine. Trapping of reactive species by reduced glutathione and butylated hydroxyanisole.
      D Ross, R Larsson, K Norbeck, R Ryhage and P Moldéus
      Molecular Pharmacology February 1985, 27 (2) 277-286;
  5. Leff, S E

    1. You have access
      Interactions of dopamine agonists with brain D1 receptors labeled by 3H-antagonists. Evidence for the presence of high and low affinity agonist-binding states.
      S E Leff, M W Hamblin and I Creese
      Molecular Pharmacology February 1985, 27 (2) 171-183;
    2. You have access
      Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum. Evidence that [3H]dopamine can label a high affinity agonist-binding state of the D1 dopamine receptor.
      S E Leff and I Creese
      Molecular Pharmacology February 1985, 27 (2) 184-192;
  6. Lund, J

    1. You have access
      Target cells for the polychlorinated biphenyl metabolite 4,4'-bis(methylsulfonyl)-2,2',5,5'-tetrachlorobiphenyl. Characterization of high affinity binding in rat and mouse lung cytosol.
      J Lund, I Brandt, L Poellinger, A Bergman, E Klasson-Wehler and J A Gustafsson
      Molecular Pharmacology February 1985, 27 (2) 314-323;

M

  1. Magruder, J D

    1. You have access
      Ethanol-induced alterations in rat synaptosomal plasma membrane phospholipids. Relationship to changes in the phospholipid methyltransferases.
      J D Magruder, M Waid-Jones and R C Reitz
      Molecular Pharmacology February 1985, 27 (2) 256-262;
  2. McKinney, M

    1. You have access
      Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115). Mediation of separate responses by high affinity and low affinity agonist-receptor conformations.
      M McKinney, S Stenstrom and E Richelson
      Molecular Pharmacology February 1985, 27 (2) 223-235;
  3. Moldéus, P

    1. You have access
      Characterization and mechanism of formation of reactive products formed during peroxidase-catalyzed oxidation of p-phenetidine. Trapping of reactive species by reduced glutathione and butylated hydroxyanisole.
      D Ross, R Larsson, K Norbeck, R Ryhage and P Moldéus
      Molecular Pharmacology February 1985, 27 (2) 277-286;
  4. Mong, S

    1. You have access
      Characterization of guinea pig myocardial leukotriene C4 binding sites. Regulation by cations and sulfhydryl-directed reagents.
      G K Hogaboom, S Mong, J M Stadel and S T Crooke
      Molecular Pharmacology February 1985, 27 (2) 236-245;

N

  1. Neumeyer, J L

    1. You have access
      A photoaffinity ligand for dopamine D2 receptors: azidoclebopride.
      H B Niznik, J H Guan, J L Neumeyer and P Seeman
      Molecular Pharmacology February 1985, 27 (2) 193-199;
  2. Niznik, H B

    1. You have access
      A photoaffinity ligand for dopamine D2 receptors: azidoclebopride.
      H B Niznik, J H Guan, J L Neumeyer and P Seeman
      Molecular Pharmacology February 1985, 27 (2) 193-199;
  3. Norbeck, K

    1. You have access
      Characterization and mechanism of formation of reactive products formed during peroxidase-catalyzed oxidation of p-phenetidine. Trapping of reactive species by reduced glutathione and butylated hydroxyanisole.
      D Ross, R Larsson, K Norbeck, R Ryhage and P Moldéus
      Molecular Pharmacology February 1985, 27 (2) 277-286;

P

  1. Poellinger, L

    1. You have access
      Characterization of the hydrophobic properties of the receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin.
      L Poellinger and D Gullberg
      Molecular Pharmacology February 1985, 27 (2) 271-276;
    2. You have access
      Target cells for the polychlorinated biphenyl metabolite 4,4'-bis(methylsulfonyl)-2,2',5,5'-tetrachlorobiphenyl. Characterization of high affinity binding in rat and mouse lung cytosol.
      J Lund, I Brandt, L Poellinger, A Bergman, E Klasson-Wehler and J A Gustafsson
      Molecular Pharmacology February 1985, 27 (2) 314-323;

R

  1. Raucy, J L

    1. You have access
      Variations among untreated rabbits in benzo(a)pyrene metabolism and its modulation by 7,8-benzoflavone.
      J L Raucy and E F Johnson
      Molecular Pharmacology February 1985, 27 (2) 296-301;
  2. Reitz, R C

    1. You have access
      Ethanol-induced alterations in rat synaptosomal plasma membrane phospholipids. Relationship to changes in the phospholipid methyltransferases.
      J D Magruder, M Waid-Jones and R C Reitz
      Molecular Pharmacology February 1985, 27 (2) 256-262;
  3. Richelson, E

    1. You have access
      Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115). Mediation of separate responses by high affinity and low affinity agonist-receptor conformations.
      M McKinney, S Stenstrom and E Richelson
      Molecular Pharmacology February 1985, 27 (2) 223-235;
  4. Ross, D

    1. You have access
      Characterization and mechanism of formation of reactive products formed during peroxidase-catalyzed oxidation of p-phenetidine. Trapping of reactive species by reduced glutathione and butylated hydroxyanisole.
      D Ross, R Larsson, K Norbeck, R Ryhage and P Moldéus
      Molecular Pharmacology February 1985, 27 (2) 277-286;
  5. Ryhage, R

    1. You have access
      Characterization and mechanism of formation of reactive products formed during peroxidase-catalyzed oxidation of p-phenetidine. Trapping of reactive species by reduced glutathione and butylated hydroxyanisole.
      D Ross, R Larsson, K Norbeck, R Ryhage and P Moldéus
      Molecular Pharmacology February 1985, 27 (2) 277-286;

S

  1. Schwarz, K R

    1. You have access
      Rapid reciprocal changes in adrenergic receptors in intact isolated hepatocytes during primary cell culture.
      K R Schwarz, S M Lanier, E A Carter, C J Homcy and R M Graham
      Molecular Pharmacology February 1985, 27 (2) 200-209;
  2. Seeman, P

    1. You have access
      A photoaffinity ligand for dopamine D2 receptors: azidoclebopride.
      H B Niznik, J H Guan, J L Neumeyer and P Seeman
      Molecular Pharmacology February 1985, 27 (2) 193-199;
  3. Seifert, W

    1. You have access
      Bromobenzene metabolism in isolated rat hepatocytes. 18O2 incorporation studies.
      D Dankovic, R E Billings, W Seifert and W G Stillwell
      Molecular Pharmacology February 1985, 27 (2) 287-295;
  4. Shahinian, A H

    1. You have access
      Assay and time course of 5-fluorouracil incorporation into RNA of L1210/0 ascites cells in vivo.
      C P Spears, J Shani, A H Shahinian, W Wolf, C Heidelberger and P V Danenberg
      Molecular Pharmacology February 1985, 27 (2) 302-307;
  5. Shani, J

    1. You have access
      Assay and time course of 5-fluorouracil incorporation into RNA of L1210/0 ascites cells in vivo.
      C P Spears, J Shani, A H Shahinian, W Wolf, C Heidelberger and P V Danenberg
      Molecular Pharmacology February 1985, 27 (2) 302-307;
  6. Shima, S

    1. You have access
      Age-related alterations in the catecholamine-sensitive adenylate cyclase system of the prostate.
      S Shima, N Akamatsu, M Hirai and H Kouyama
      Molecular Pharmacology February 1985, 27 (2) 218-222;
  7. Spears, C P

    1. You have access
      Assay and time course of 5-fluorouracil incorporation into RNA of L1210/0 ascites cells in vivo.
      C P Spears, J Shani, A H Shahinian, W Wolf, C Heidelberger and P V Danenberg
      Molecular Pharmacology February 1985, 27 (2) 302-307;
  8. Spivak, C E

    1. You have access
      Triphenylmethylphosphonium blocks the nicotinic acetylcholine receptor noncompetitively.
      C E Spivak and E X Albuquerque
      Molecular Pharmacology February 1985, 27 (2) 246-255;
  9. Stadel, J M

    1. You have access
      Characterization of guinea pig myocardial leukotriene C4 binding sites. Regulation by cations and sulfhydryl-directed reagents.
      G K Hogaboom, S Mong, J M Stadel and S T Crooke
      Molecular Pharmacology February 1985, 27 (2) 236-245;
  10. Stenstrom, S

    1. You have access
      Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115). Mediation of separate responses by high affinity and low affinity agonist-receptor conformations.
      M McKinney, S Stenstrom and E Richelson
      Molecular Pharmacology February 1985, 27 (2) 223-235;
  11. Stillwell, W G

    1. You have access
      Bromobenzene metabolism in isolated rat hepatocytes. 18O2 incorporation studies.
      D Dankovic, R E Billings, W Seifert and W G Stillwell
      Molecular Pharmacology February 1985, 27 (2) 287-295;

T

  1. Tsujimoto, G

    1. You have access
      Desensitization of beta-adrenergic receptor-mediated vascular smooth muscle relaxation.
      G Tsujimoto and B B Hoffman
      Molecular Pharmacology February 1985, 27 (2) 210-217;

W

  1. Waid-Jones, M

    1. You have access
      Ethanol-induced alterations in rat synaptosomal plasma membrane phospholipids. Relationship to changes in the phospholipid methyltransferases.
      J D Magruder, M Waid-Jones and R C Reitz
      Molecular Pharmacology February 1985, 27 (2) 256-262;
  2. Wolf, W

    1. You have access
      Assay and time course of 5-fluorouracil incorporation into RNA of L1210/0 ascites cells in vivo.
      C P Spears, J Shani, A H Shahinian, W Wolf, C Heidelberger and P V Danenberg
      Molecular Pharmacology February 1985, 27 (2) 302-307;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 27, Issue 2
1 Feb 1985
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics